Young kids rarely get very sick from COVID-19, finds a new study

Written By :  Roshni Dhar
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-11-30 04:00 GMT   |   Update On 2023-11-30 04:00 GMT

As a rule, infants and young children rarely develop severe or enduring cases of COVID-19. And those who do almost invariably suffer from some other serious medical problem.It's not that kids don't get infected. They do. More than 90% of kids age 4 and under in the United States test positive for previous or current infection by SARS-CoV-2, the coronavirus that causes this...

Login or Register to read the full article

As a rule, infants and young children rarely develop severe or enduring cases of COVID-19. And those who do almost invariably suffer from some other serious medical problem.

It's not that kids don't get infected. They do. More than 90% of kids age 4 and under in the United States test positive for previous or current infection by SARS-CoV-2, the coronavirus that causes this respiratory infection.

"For almost every infectious disease, the most vulnerable populations are at the extremes of age -- the very young and the very old," said Stanford Medicine professor of microbiology and immunology and of pathology Bali Pulendran, PhD. "But with COVID-19, the young are spared while the old are emphatically not. That's been a mystery."

There's evidence for these and other hypotheses. But much of the solution to the mystery COVID-19 poses may reside inside little kids' noses.

In the blood of SARS-CoV-2-infected adults, SARS-specific antibody levels rose quickly to a robust peak, then dropped off precipitously, declining by 10-fold within six months.

Infants' blood-borne antibodies to SARS-CoV-2 were a little slower to spike upward in response to SARS-CoV-2 infection. But in stark contrast to adults, their antibody levels never dropped -- they either plateaued at a high level or kept on rising throughout the 300-day observation period, eventually rivaling those of the adults at peak.

The kids' antibodies, he noted, tended to be somewhat narrow spectrum: highly effective against the original invading variant, but providing less protection against other SARS-CoV-2 variants.

Reference: Florian Wimmers, Allison R. Burrell, Yupeng Feng, Hong Zheng, Prabhu S. Arunachalam, Mengyun Hu, Sara Spranger, Lindsay E. Nyhoff, Devyani Joshi, Meera Trisal, Mayanka Awasthi, Lorenza Bellusci, Usama Ashraf, Sangeeta Kowli, Katherine C. Konvinse, Emily Yang, Michael Blanco, Kathryn Pellegrini, Gregory Tharp, Thomas Hagan, R. Sharon Chinthrajah, Tran T. Nguyen, Alba Grifoni, Alessandro Sette, Kari C. Nadeau, David B. Haslam, Steven E. Bosinger, Jens Wrammert, Holden T. Maecker, Paul J. Utz, Taia T. Wang, Surender Khurana, Purvesh Khatri, Mary A. Staat, Bali Pulendran. Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth. Cell, 2023; 186 (21): 4632 DOI: 10.1016/j.cell.2023.08.044

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News